These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 9499087)

  • 1. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
    Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
    J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors.
    Fujita K; Omura S; Silver J
    J Gen Virol; 1997 Mar; 78 ( Pt 3)():619-25. PubMed ID: 9049413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation.
    Meusser B; Sommer T
    Mol Cell; 2004 Apr; 14(2):247-58. PubMed ID: 15099523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
    Vincent MJ; Raja NU; Jabbar MA
    J Virol; 1993 Sep; 67(9):5538-49. PubMed ID: 8350411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.
    de Virgilio M; Weninger H; Ivessa NE
    J Biol Chem; 1998 Apr; 273(16):9734-43. PubMed ID: 9545309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum.
    Binette J; Dubé M; Mercier J; Halawani D; Latterich M; Cohen EA
    Retrovirology; 2007 Oct; 4():75. PubMed ID: 17937819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S; Perrin C; Akari H; Strebel K
    J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the betaTrCP in the ubiquitination and stability of the HIV-1 Vpu protein.
    Belaïdouni N; Marchal C; Benarous R; Besnard-Guérin C
    Biochem Biophys Res Commun; 2007 Jun; 357(3):688-93. PubMed ID: 17445772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
    Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV
    J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.
    Willey RL; Maldarelli F; Martin MA; Strebel K
    J Virol; 1992 Dec; 66(12):7193-200. PubMed ID: 1433512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor.
    Keller SH; Lindstrom J; Taylor P
    J Biol Chem; 1998 Jul; 273(27):17064-72. PubMed ID: 9642271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome-dependent degradation of the human estrogen receptor.
    Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains.
    Schubert U; Bour S; Ferrer-Montiel AV; Montal M; Maldarell F; Strebel K
    J Virol; 1996 Feb; 70(2):809-19. PubMed ID: 8551619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity.
    Qu D; Teckman JH; Omura S; Perlmutter DH
    J Biol Chem; 1996 Sep; 271(37):22791-5. PubMed ID: 8798455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.
    Lenburg ME; Landau NR
    J Virol; 1993 Dec; 67(12):7238-45. PubMed ID: 8230446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4.
    Raja NU; Vincent MJ; abdul Jabbar M
    Virology; 1994 Oct; 204(1):357-66. PubMed ID: 8091666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human immunodeficiency virus type 1 Vpu protein: a potential regulator of proteolysis and protein transport in the mammalian secretory pathway.
    Vincent MJ; Abdul Jabbar M
    Virology; 1995 Nov; 213(2):639-49. PubMed ID: 7491787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.
    Margottin F; Bour SP; Durand H; Selig L; Benichou S; Richard V; Thomas D; Strebel K; Benarous R
    Mol Cell; 1998 Mar; 1(4):565-74. PubMed ID: 9660940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu.
    Magadán JG; Bonifacino JS
    J Virol; 2012 Jan; 86(2):757-72. PubMed ID: 22090097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation.
    Bour S; Schubert U; Strebel K
    J Virol; 1995 Mar; 69(3):1510-20. PubMed ID: 7853484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.